We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
(+5%)
Cap. Flow
+$6.41B
Cap. Flow
% of AUM
5.41%
Top 10 Holdings %
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.02B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$944M |
| 3 |
AT&T
T
|
+$753M |
| 4 |
Vanguard Extended Market ETF
VXF
|
+$553M |
| 5 |
Linde
LIN
|
+$379M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
APC
Anadarko Petroleum
APC
|
+$331M |
| 2 |
FDC
First Data Corporation
FDC
|
+$331M |
| 3 |
GWR
Genesee & Wyoming Inc.
GWR
|
+$312M |
| 4 |
Blackstone
BX
|
+$277M |
| 5 |
FirstEnergy
FE
|
+$261M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.59% |
| 2 | Technology | 10.75% |
| 3 | Financials | 9.31% |
| 4 | Consumer Discretionary | 6.45% |
| 5 | Communication Services | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLBK
3576
DELISTED
Old Line Bancshares, Inc.
OLBK
| $303K | ﹤0.01% |
+10,409
| New | +$284K |
|
3577
Arrow Financial
AROW
$659M
| $301K | ﹤0.01% |
10,149
-259
| -2% | -$7.47K |
|
3578
Paysign
PAYS
$501M
| $301K | ﹤0.01% |
29,820
+11,786
| +65% | +$157K |
|
|
TPIC
3579
DELISTED
TPI Composites
TPIC
| $301K | ﹤0.01% |
16,026
-156,631
| -91% | -$3.34M |
|
|
BHR
3580
Braemar Hotels & Resorts
BHR
$156M
| $300K | ﹤0.01% |
32,328
-17,510
| -35% | -$159K |
|
|
CPRX
3581
DELISTED
Catalyst Pharmaceutical
CPRX
| $300K | ﹤0.01% |
56,406
+8,861
| +19% | +$47.2K |
|
3582
CryoPort
CYRX
$761M
| $297K | ﹤0.01% |
18,172
+6,620
| +57% | +$133K |
|
3583
PUT
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$154M
| $297K | ﹤0.01% |
195
-19,550
| -99% | -$31.1M |
|
|
HOME
3584
DELISTED
At Home Group Inc.
HOME
| $297K | ﹤0.01% |
30,867
-11,456
| -27% | -$78.3K |
|
|
OLP
3585
One Liberty Properties
OLP
$530M
| $296K | ﹤0.01% |
10,757
-1,146
| -10% | -$32.1K |
|
3586
iShares MSCI France ETF
EWQ
$335M
| $294K | ﹤0.01% |
+9,770
| New | +$292K |
|
3587
First Trust Short Duration Managed Municipal ETF
FSMB
$619M
| $294K | ﹤0.01% |
14,365
-172,976
| -92% | -$3.54M |
|
3588
Novavax
NVAX
$1.2B
| $294K | ﹤0.01% |
58,655
+17,095
| +41% | +$93.6K |
|
|
FLY
3589
DELISTED
Fly Leasing Limited
FLY
| $294K | ﹤0.01% |
+14,315
| New | +$267K |
|
|
ORAN
3590
DELISTED
Orange
ORAN
| $293K | ﹤0.01% |
+18,799
| New | +$284K |
|
|
DHIL
3591
DELISTED
Diamond Hill
DHIL
| $292K | ﹤0.01% |
2,117
-315
| -13% | -$42.8K |
|
|
VIVO
3592
DELISTED
Meridian Bioscience Inc
VIVO
| $292K | ﹤0.01% |
30,749
+2,990
| +11% | +$31.5K |
|
3593
nLIGHT
LASR
$3.88B
| $291K | ﹤0.01% |
18,517
+3,559
| +24% | +$55.2K |
|
3594
Wave Life Sciences
WVE
$1.09B
| $291K | ﹤0.01% |
14,157
+6,091
| +76% | +$140K |
|
3595
Greenlight Captial
GLRE
$552M
| $289K | ﹤0.01% |
27,496
+7,238
| +36% | +$68.2K |
|
|
JCP
3596
PUT
DELISTED
J.C. Penney Company, Inc.
JCP
| $289K | ﹤0.01% |
324,600
-33,000
| -9% | -$27.7K |
|
3597
CALL
Equinix
EQIX
$101B
| $288K | ﹤0.01% |
+500
| New | +$269K |
|
3598
First Mid Bancshares
FMBH
$1.39B
| $288K | ﹤0.01% |
8,316
+651
| +8% | +$21.7K |
|
|
UMH
3599
UMH Properties
UMH
$1.29B
| $288K | ﹤0.01% |
20,450
-3,272
| -14% | -$42.4K |
|
|
AERI
3600
CALL
DELISTED
Aerie Pharmaceuticals
AERI
| $288K | ﹤0.01% |
15,000
| – | – |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q3 2019 Portfolio in Review
As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.
- Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
- Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
- Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
- Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
- Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
- Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
- Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.
Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.